Four teams race to find the mysterious cause of a group of blood cancers.
JAK2 MUTATIONS AT A GLANCE
- Involved in: blood cancers and disorders including polycythemia vera, primary myelofibrosis, thrombocythemia, leukemia.
- Testing requires: a blood draw. Bone marrow samples occasionally used.
- Prognosis: Patients with a JAK2 mutation have a lower survival rate and higher rate of blood clots when compared to patients with a CALR mutation.
- Treatment: Ruxolitinib may improve quality of life in patients with a JAK2 mutation.
This Gene is also known as: JTK10, THCYT3
Click the link below for the complete article…[contentcards url=”https://www.cureforward.com/stories/gene-stories/jak2/” target=”_blank”]